Results 91 to 100 of about 333,361 (210)

Data-Driven Prediction of CRISPR-Based Transcription Regulation for Programmable Control of Metabolic Flux [PDF]

open access: yesarXiv, 2017
Multiplex and multi-directional control of metabolic pathways is crucial for metabolic engineering to improve product yield of fuels, chemicals, and pharmaceuticals. To achieve this goal, artificial transcriptional regulators such as CRISPR-based transcription regulators have been developed to specifically activate or repress genes of interest.
arxiv  

Small CRISPR RNAs Guide Antiviral Defense in Prokaryotes [PDF]

open access: green, 2008
Stan J. J. Brouns   +9 more
openalex   +1 more source

274 Development of CTX112 a next generation allogeneic multiplexed CRISPR-edited CART cell therapy with disruptions of the TGFBR2 and Regnase-1 genes for improved manufacturing and potency

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Sarah Cohen   +40 more
doaj   +1 more source

324 Allogeneic CAR T cells targeting Liv-1 for breast cancer

open access: yesJournal for ImmunoTherapy of Cancer, 2023
Minh Pham   +9 more
doaj   +1 more source

DeepFM-Crispr: Prediction of CRISPR On-Target Effects via Deep Learning [PDF]

open access: yesarXiv
Since the advent of CRISPR-Cas9, a groundbreaking gene-editing technology that enables precise genomic modifications via a short RNA guide sequence, there has been a marked increase in the accessibility and application of this technology across various fields.
arxiv  

A bacterial gene-drive system efficiently edits and inactivates a high copy number antibiotic resistance locus. [PDF]

open access: yes, 2019
Gene-drive systems in diploid organisms bias the inheritance of one allele over another. CRISPR-based gene-drive expresses a guide RNA (gRNA) into the genome at the site where the gRNA directs Cas9-mediated cleavage.
Bier, Ethan   +3 more
core   +1 more source

CRISPI: a CRISPR interactive database [PDF]

open access: hybrid, 2009
Christine Rousseau   +3 more
openalex   +1 more source

High frequency CCR5 editing in human hematopoietic stem progenitor cells protects xenograft mice from HIV infection

open access: yesNature Communications
The only cure of HIV has been achieved in a small number of people who received a hematopoietic stem cell transplant (HSCT) comprising allogeneic cells carrying a rare, naturally occurring, homozygous deletion in the CCR5 gene. The rarity of the mutation
Daniel T. Claiborne   +15 more
doaj   +1 more source

Home - About - Disclaimer - Privacy